Gordon K. Wilcock, MD

Affiliations: 
Clinical Medicine University of Bristol, Bristol, England, United Kingdom 
Area:
http://www.researchprofiles.collexis.com/jad/expert.asp?u_id=94
Website:
http://www.ndm.ox.ac.uk/principal-investigators/researcher/gordon-wilcock
Google:
"Gordon Wilcock"
Bio:

http://www.medsci.ox.ac.uk/optima/our-research/researcher-profiles/gordon-wilcock

Mean distance: 106866
 
Cross-listing: Alzheimer's Tree

BETA: Related publications

Publications

You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect.

Howard R, Zubko O, Bradley R, et al. (2019) Minocycline at 2 Different Dosages vs Placebo for Patients With Mild Alzheimer Disease: A Randomized Clinical Trial. Jama Neurology
Morley JE, Morris JC, Berg-Weger M, et al. (2015) Brain Health: The Importance of Recognizing Cognitive Impairment: An IAGG Consensus Conference. Journal of the American Medical Directors Association. 16: 731-9
Esiri M, Chance S, Joachim C, et al. (2015) Cerebral amyloid angiopathy, subcortical white matter disease and dementia: literature review and study in OPTIMA. Brain Pathology (Zurich, Switzerland). 25: 51-62
Esiri MM, Joachim C, Sloan C, et al. (2014) Cerebral subcortical small vessel disease in subjects with pathologically confirmed Alzheimer disease: a clinicopathologic study in the Oxford Project to Investigate Memory and Ageing (OPTIMA). Alzheimer Disease and Associated Disorders. 28: 30-5
Galasko D, Golde T, Wilcock G. (2012) Recent Alzheimer's disease research highlights. Alzheimer's Research & Therapy. 4: 14
Dean K, Wilcock G. (2012) Living with mild cognitive impairment: The patient's and carer's experience International Psychogeriatrics. 24: 871-881
Sheng Y, Lee JH, Medhurst AD, et al. (2012) Preservation of cortical histamine H3 receptors in ischemic vascular and mixed dementias. Journal of the Neurological Sciences. 315: 110-4
Tondelli M, Wilcock GK, Nichelli P, et al. (2012) Structural MRI changes detectable up to ten years before clinical Alzheimer's disease. Neurobiology of Aging. 33: 825.e25-36
Lehmann DJ, Schuur M, Warden DR, et al. (2012) Transferrin and HFE genes interact in Alzheimer's disease risk: the Epistasis Project. Neurobiology of Aging. 33: 202.e1-13
Mohamed NE, Zhao Y, Lee JH, et al. (2011) Upregulation of AMPA receptor GluR2 (GluA2) subunits in subcortical ischemic vascular dementia is repressed in the presence of Alzheimer's disease. Neurochemistry International. 58: 820-5
See more...